{'fraction_non_alphanumeric': 0.028827529363280445, 'fraction_numerical': 0.024788790438903772, 'mean_word_length': 5.384817787133272, 'pattern_counts': {'":': 0, '<': 5, '<?xml version=': 0, '>': 1, 'https://': 6, 'lorem ipsum': 0, 'www.': 5, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 3, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics

Phytochemicals of medicinal plants encompass a diverse chemical space for drug discovery. India is rich with a flora of indigenous medicinal plants that have been used for centuries in traditional Indian medicine to treat human maladies. A comprehensive online database on the phytochemistry of Indian medicinal plants will enable computational approaches towards natural product based drug discovery. In this direction, we present, IMPPAT, a manually curated database of 1742 Indian Medicinal Plants, 9596 Phytochemicals, And 1124 Therapeutic uses spanning 27074 plant-phytochemical associations and 11514 plant-therapeutic associations. Notably, the curation effort led to a non-redundant in silico library of 9596 phytochemicals with standard chemical identifiers and structure information. Using cheminformatic approaches, we have computed the physicochemical, ADMET (absorption, distribution, metabolism, excretion, toxicity) and drug-likeliness properties of the IMPPAT phytochemicals. We show that the stereochemical complexity and shape complexity of IMPPAT phytochemicals differ from libraries of commercial compounds or diversity-oriented synthesis compounds while being similar to other libraries of natural products. Within IMPPAT, we have filtered a subset of 960 potential druggable phytochemicals, of which majority have no significant similarity to existing FDA approved drugs, and thus, rendering them as good candidates for prospective drugs. IMPPAT database is openly accessible at: https://cb.imsc.res.in/imppat.

Natural products continue to play a significant role in pharmaceutical industry [1][2][3][4] as new sources of drugs. However, recently there has been a decline in the number of marketable drugs derived from natural sources 3,4 . Furthermore, the majority of these drugs fall into already known structural scaffolds as due importance has not been given to unexplored sources of natural products for drug discovery 4 . As a result, lately, there has been significant interest in applying interdisciplinary approaches 5 to expand the novel chemical scaffold libraries for drug discovery.
India is well known for its practice of traditional medicine and ethnopharmacology 6 . It is noteworthy that traditional Indian medicinal formulations are multi-component mixtures whose therapeutic use is based on empirical knowledge rather than a mechanistic understanding of the active ingredients in the mixture 6 . Until recently, knowledge of traditional Indian medicine including important medicinal plants and their formulations were buried within books such as Indian Materia Medica 7 and Ayurveda Materia Medica 8 . The nondigital nature of this information limited their effective use towards new drug discovery 5 . Hence, digitization of this knowledge into a comprehensive database on Indian medicinal plants, phytochemistry and ethnopharmacology will enable researchers to apply computational approaches towards drug discovery.
Availability of a curated database of information on plants, their associated natural products and a repository of their chemical structures, can help in in silico drug discovery. In this direction, there has been significant recent progress in the development of databases 9-17 on natural products with a focus on phytochemistry of edible and herbaceous plants. Examples of such databases include CVDHD 12 , KNAPSACK 13 , Nutrichem 9,10 , Phytochemica 11 , TCMID 15 , TCM@Taiwan 14 and TCM-Mesh 16 which can facilitate virtual screening of prospective drug compounds or aid in the investigation of plant-disease associations. However, from the perspective of traditional Indian medicine, there have been relatively few efforts to build online databases that include Indian medicinal plants, their phytochemicals and therapeutic uses. Previously, Polur et al. 18 compiled information on 295 ayurvedic Indian medicinal plants, their 1829 phytochemicals and therapeutic uses. Subsequently, Polur et al. 18 studied the structural similarity between their library of 1829 phytochemicals and drugs in the DrugBank 19 database to predict pharmacologically active natural compounds. Recently, the Phytochemica 11 database gathered information on 5 Indian medicinal plants and their 963 phytochemicals. In addition, Phytochemica 11 provided chemical structures and pharmacological properties of the phytochemicals within their database. Other efforts to build online databases for traditional Indian medicine has largely been limited to cataloguing medicinal plants and their therapeutic uses rather than capturing the phytochemicals that are vital for drug discovery. On the other hand, in contrast to the above mentioned online databases, more comprehensive databases are available for Chinese medicinal plants [14][15][16] . For example, TCM-MeSH 16 is an online database for traditional Chinese medicine which captures phytochemical compositions and therapeutic uses for more than 6000 Chinese medicinal plants.
We therefore have built a manually curated database, IMPPAT, containing 1742 Indian Medicinal Plants, 9596 Phytochemicals, And 1124 T herapeutic uses. In addition, the IMPPAT database has linked Indian medicinal plants to 974 openly accessible traditional Indian medicinal formulations. Importantly, our curation efforts have led to a non-redundant in silico chemical library of 9596 phytochemicals with two-dimensional (2D) and three-dimensional (3D) chemical structures. For the 9596 phytochemicals in our database, we have computed physicochemical properties and predicted Absorption, distribution, metabolism, excretion and toxicity (ADMET) properties using cheminformatic tools [20][21][22] . We then employed cheminformatic approaches to evaluate the drug-likeliness of the phytochemicals in our in silico chemical library using multiple scoring schemes such as Lipinski's rule of five (RO5) 23 , Oral PhysChem Score (Traffic Lights) 24 , GlaxoSmithKline's (GSK's) 4/400 25 , Pfizer's 3/75 26 , Veber rule 27 and Egan rule 28 . We found a subset of 960 phytochemicals of Indian medicinal plants that are potentially druggable in our chemical library of 9596 phytochemicals based on multiple scoring schemes. We also provide predicted interactions between phytochemicals in our database and human target proteins from STITCH 29 database. Table 1 provides a comparison of the IMPPAT database with previous efforts by Polur et al. 18 and Phytochemica 11 to build dedicated digital resource on phytochemical composition of Indian medicinal plants. In summary, IMPPAT is the largest database on phytochemicals of Indian medicinal plants to date, and this resource is a culmination of our efforts to digitize the wealth of information contained within traditional Indian medicine. IMPPAT provides an integrated platform to apply cheminformatic 30 approaches to accelerate natural product based drug discovery. IMPPAT is openly accessible at: https://cb.imsc.res.in/imppat.

Curated list of Indian medicinal plants.
In the preliminary phase of the database construction ( Fig. 1 18 . While this list is no longer publicly available, the Nutrichem 9,10 database on phytochemical composition and therapeutic uses of plant-based food products has incorporated the information compiled by Polur et al. 18 . From the Phytochemica 11 and Nutrichem 9,10 databases, we gathered information on the phytochemical composition of more than 400 Indian medicinal plants. Note that our comprehensive list covers a wide spectrum of Indian medicinal plants which includes apart from Ayurveda, other systems of traditional Indian medicine such as Siddha and Unani. In the third stage of data mining for phytochemical composition, we performed text mining of abstracts from published research articles in PubMed 42 using natural language processing (NLP) 43 . Using in-house Python scripts and a dataset of known plant-phytochemical associations, we identified keywords in PubMed abstracts which imply plant-phytochemical associations (Supplementary Table S1). We then used the selected keywords listed in Supplementary Table S1 to mine PubMed abstracts to identify and incorporate additional references for plant-phytochemical associations in our database. In total, our database captures the phytochemical composition of 1742 Indian medicinal plants (Supplementary Table S2). The literature references for plant-phytochemical associations are listed in our database in the form of ISBN or DOI identifiers for books and PubMed identifiers (PMIDs) for journal articles. We would like to mention a potential bias in the list of plant-phytochemical associations compiled from scientific literature. Our database most-likely contains high-quality yet incomplete information on phytochemical composition of Indian medicinal plants. That is, phytochemicals listed are most-likely produced by the corresponding Indian medicinal plant but other phytochemicals not listed in our database cannot be ruled out from being also produced by the same plant due to possible lack of scientific literature. Moreover, the scientific literature will most probably have more information on phytochemical composition of well-studied or sequenced Indian medicinal plants such as Catharanthus roseus. Thus, future updates of this database will be needed to capture additional information on phytochemical composition of Indian medicinal plants. Nevertheless, one can argue that for the discovery of novel molecules it is more important to know the list of phytochemicals produced by an herb rather than the list of phytochemicals not produced by an herb.
Annotation, curation and filtering of identified phytochemicals. An overarching goal of this work is to create a platform for exploring the chemistry of the phytochemicals of Indian medicinal plants. Evaluation of the phytochemicals of Indian medicinal plants for their druggability or drug-likeliness will facilitate the identification of molecules for drug discovery. We would like to emphasize that synonymous chemical names are pervasive across the literature on traditional Indian medicine which were mined to construct this database. In order to remove redundancy, we manually annotated the common names of phytochemicals of Indian medicinal plants compiled from literature sources with documented synonyms and standard chemical identifiers ( Fig. 1 48 and Human Metabolome database (HMDB) 49 . While assigning standard identifiers to phytochemicals in our database, we have chosen the following priority order: Pubchem 44 , CHEBI 45 , CAS, CHEMSPIDER 46 , KNAPSACK 47 , CHEMFACES, FOODB, NIST Chemistry webbook 48 and HMDB 49 . We highlight that this extensive manual curation effort led to the mapping of more than 15000 common names of phytochemicals used across literature sources to a unique set of 9596 standard chemical identifiers. Phytochemicals which could not be mapped to standard chemical identifiers were excluded from our finalized database. Our choice to include only phytochemicals with standard identifiers and structure information was dictated by our goal to investigate the chemistry and druggability of phytochemicals of Indian medicinal plants. We remark that the 2D structure information for the unique set of 9596 IMPPAT phytochemicals was obtained using the standard chemical identifiers from the respective databases. We have also determined the chemical classification of the IMPPAT phytochemicals using ClassyFire 50 (http://classyfire.wishartlab.com/). ClassyFire 50 gives a hierarchical classification for each chemical compound into kingdom (organic or inorganic), followed by super-class, followed by class, followed by sub-class. Note that ClassyFire classifies organic compounds into 26 super-classes. In a nutshell, this largely manual effort to compile a non-redundant Figure 1. Schematic overview of the IMPPAT database construction pipeline. Briefly, we first compiled a comprehensive list of Indian medicinal plants from various sources. We next mined specialized books on Indian traditional medicine, existing databases and PubMed abstracts of journal articles to gather information on phytochemicals of Indian medicinal plants. We then manually annotated, curated and indexed names of identified phytochemicals with standard identifiers to build a non-redundant library of phytochemicals. This manual curation effort led to a unique list of plant-phytochemical associations. We also classified the Indian medicinal plants into taxonomic families and phytochemicals into chemical classes. Subsequently, we gathered ethnopharmacological information from books on traditional Indian medicine to build a unique list of plant-therapeutic use associations. We also extracted publicly accessible information on traditional medicine formulations from TKDL database to build a list of plant-formulation associations. Lastly, we have used cheminformatic tools to obtain the 3D structures, physicochemical properties, druggability scores, predicted ADMET properties and predicted target human proteins of phytochemicals.
Scientific REPoRTS | (2018) 8:4329 | DOI:10.1038/s41598-018-22631-z chemical library of 9596 phytochemicals of Indian medicinal plants with standard identifiers and structure information will serve as valuable resource for natural product-based drug discovery in future. Moreover, the use of standard chemical identifiers will enable effortless integration of our IMPPAT database with other data sources.

Therapeutic uses of Indian medicinal plants.
Another goal of our database is to compile ethnopharmacological information on Indian medicinal plants. Towards this goal, we manually compiled the medicinal (therapeutic) uses of Indian medicinal plants from books on Indian traditional medicine [32][33][34][35][36][37][38][39][40][41]48,[51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67] . Apart from books, Polur et al. 18 had previously compiled a list of therapeutic uses for 295 ayurvedic Indian medicinal plants, and this information was extracted from the Nutrichem 9,10 database. To ensure high quality, we manually curated information on therapeutic uses of Indian medicinal plants and consciously avoided automated text mining to retrieve additional information on plant-therapeutic associations. We remark that our database has manually compiled therapeutic uses of Indian medicinal plants from standard books on traditional Indian medicine which contain accumulated experience-based knowledge on treating human diseases. Furthermore, we manually annotated and standardized the compiled therapeutic uses of Indian medicinal plants from the above sources with identifiers from the Disease Ontology 68 , Online Mendelian Inheritance in Man (OMIM) 69 , Unified Medical Language System (UMLS) 70 and Medical Subject Headings (MeSH) 71 databases. To the best of our knowledge, this is the first large-scale attempt to link the ethnopharmacological information on Indian medicinal plants with standardized vocabulary in modern medicine. Note that databases of gene-disease associations 72 and disease-symptom associations 73 usually provide disease information in form of identifiers from OMIM, UMLS and MeSH databases, and in future, information from such databases can be effortlessly integrated into IMPPAT database.

Traditional formulations of Indian medicinal plants. Traditional knowledge digital library (TKDL)
(http://www.tkdl.res.in) is a knowledgebase of traditional Indian medicinal formulations. A traditional medicinal formulation is often a multi-component mixture derived from plant, animal and other sources which is used for treating disease based on specific indication. For example, Thinavu Sori Soolaiku Ennai (TKDL Identifier: HM02/36) is a medicinal formulation in traditional Indian system of medicine, Siddha, which is used to treat allergic rashes, and this formulation mainly consists of extracts of medicinal plants, Plumbago zeylanica, Sesamum orientale (also called Sesamum indicum) and Cuminum cyminum. According to TKDL, there are more than 250000 formulations of Ayurveda, Siddha and Unani of which 1200 representative formulations are openly accessible via their database. To exhibit the broader utility of our database to phytopharmacology, we have also compiled and curated the subset of 1200 openly accessible formulations in TKDL which contain at least one of the 1742 Indian medicinal plants in our database. This process led to associations between 321 Indian medicinal plants in our database and 974 traditional Indian medicinal formulations which are openly accessible through TKDL database (Fig. 1). We emphasize that our database has only incorporated open digital information on traditional Indian medicinal formulations from TKDL database. However, we are aware of the vast literature 7,8,74 on traditional Indian medicinal formulations, especially in books, and in the future, a significant effort will be needed to digitize and integrate such information into our database.
3D structure of phytochemicals. We have generated lowest energy 3D conformational structure of IMPPAT phytochemicals using Balloon 75 (http://users.abo.fi/mivainio/balloon/) and Open Babel 76 (http://openbabel.org/wiki/Main_Page). Balloon generates 3D conformers of input 2D structures from scratch and optimizes them using Merck Molecular Force Field (MMFF94). The lowest energy 3D conformer was selected from 20 generated conformations for a given phytochemical. Of the 9596 IMPPAT phytochemicals, Balloon successfully generated 3D structures for 8021 phytochemicals. For the remaining 1575 phytochemicals, the lowest energy 3D conformer was generated using Open Babel with MMFF94 force field. We remark that our preferred choice of Balloon to generate lowest energy 3D structures of IMPPAT phytochemicals was motivated by similar choice made by two other databases of 3D structures of natural products, namely, KNApSAcK-3D 47 and TIPdb-3D 77 .
Physicochemical properties of phytochemicals. We used FAF-Drugs4 webserver 20 and RDKit 21 to compute the following physicochemical properties of the IMPPAT phytochemicals: molecular weight, octanol-water partition coefficient (logP), logP at physiological pH of 7.4 (logD), logarithm of water solubility (logSw), number of stereocenters, stereochemical complexity 78 which is the fraction of carbon atoms which are stereogenic, Fsp 3 which is the fraction of carbon atoms that are sp 3 hybridized 79 , topological polar surface area (TPSA), charge of the compound, number of hydrogen bond donors and acceptors, number of smallest set of smallest rings (SSSR) which is the number of smallest ring building blocks required for forming other ring systems, size of the biggest system ring which is the number of atoms present in the biggest ring system, number of rotatable and rigid bonds, number of charged groups, total charge of the compound, number of carbon, heteroand heavy atoms, and ratio between the number of non-carbon atoms and the number of carbon atoms.
ADMET properties of phytochemicals. Absorption, distribution, metabolism, excretion and toxicity (ADMET) properties have been implicated as one of the reasons for high attrition rate of candidates from drug development pipeline. Thus, we used admetSAR 22 webserver to predict the ADMET properties of the phytochemicals. The predicted properties which influence absorption include Human Intestinal Absorption (HIA) 80 , Blood Brain Barrier (BBB) permeability 80 , Caco-2 permeability 81 and likeliness of being P-glycoprotein substrate 82 . The predicted properties which affect phytochemical metabolism include the ability to inhibit several CYP450 enzymes or likeliness of being a substrate to CYP450 enzymes [83][84][85] . Lastly, toxicity predictions are based on computational models for Ames test for mutagenicity 86 , carcinogenicity, biodegradability 87 , rat acute toxicity 88 and hERG inhibition 89,90 . Note that our choice of admetSAR 22 was motivated by the same choice made by DrugBank 19 database (https://www.drugbank.ca/) which is the widely-used repository of approved and experimental drugs.
Scientific REPoRTS | (2018) 8:4329 | DOI:10.1038/s41598-018-22631-z Druggability scores of phytochemicals. We used FAF-Drugs4 webserver 20 to test the druggability of the phytochemicals based on multiple scoring schemes, namely, Lipinski's rule of five (RO5) 23 , Oral PhysChem 24 score (Traffic Lights), GlaxoSmithKline's (GSK's) 4/400 25 , Pfizer's 3/75 26 , Veber rule 27 and Egan rule 28 . Lipinski's RO5 23 is a classical rule of thumb to filter druggable small molecules based on four physiochemical properties. RO5 considers a small molecule to be druggable if it has ≤5 hydrogen bond donors, ≤10 hydrogen bond acceptors, molecular weight <500 Daltons and logP ≤5. If a small molecule violates none of the above rules it is assigned a RO5 value of 0, and on the other extreme if it violates all the above rules it is assigned a RO5 value of 4. OralPhysChem 24 score is another method for filtering druggable small molecules which is based on five physiochemical properties, namely, aqueous solubility, logP, corrected molecular weight for presence of halogen atoms, TPSA and number of rotatable bonds. OralPhysChem score ranges from 0 to 10 whereby 0 signifies high druggability while 10 signifies low druggability of the small molecule. GSK's 4/400 25 is another filter based on a number of ADMET assays carried out in GSK. Briefly, a small molecule is considered more druggable and labelled 'Good' by GSK's 4/400 score if it has both molecular weight <400 Daltons and logP <4 while it is considered less druggable and labelled 'Bad' if at least one of the rules is not satisfied. Pfizer's 3/75 26 rule is used to filter small molecules which are more prone to be toxic, and hence, less likely to be druggable. Pfizer's 3/75 rule considers small molecules with logP <3 and TPSA > 75 Å 2 to be 'Good' as they are likely to be less toxic, and hence, more likely to be druggable, and small molecules which do not satisfy one of the two rules are labelled as 'Warning' , and small molecules which violate both rules are labelled as 'Bad' . Veber rule 27 considers small molecules to have good oral bioavailability if they satisfy number of rotatable bonds ≤10 and TPSA ≤140 Å 2 , and small molecules which fail these criteria are considered to have low bioavailability. Similarly, Egan rule 28 considers small molecules to have good oral bioavailability if they satisfy −1.0 ≤logP ≤5.8 and TPSA ≤130 Å 2 , and small molecules which fail these criteria are considered to have low bioavailability. We filtered phytochemicals with no RO5 violation, net Traffic Lights value of zero and satisfying GSK's 4/400, Pfizer's 3/75, Veber rule and Egan rule as druggable. We further computed the weighted quantitative estimate of drug-likeness (QEDw) 91 score using FAF-QED webserver 20 for the filtered list of druggable phytochemicals within IMPPAT and TCM-Mesh 16 . QEDw is a druggability score for small molecules proposed by Bickerton et al. 91 which is the weighted geometric mean of molecular weight, logP, number of hydrogen bond donors, number of hydrogen bond acceptors, TPSA, number of rotatable bonds, number of aromatic rings and number of structural alerts. Note that QEDw is a continuous score between 0 and 1 where 0 signifies low druggability and 1 signifies high druggability.
Predicted human target proteins of phytochemicals. We have extracted the predicted human target proteins of IMPPAT phytochemicals from STITCH 29 database (http://stitch1.embl.de/). Note that STITCH 29 database is the largest resource on predicted interactions between chemicals and their target proteins. From the STITCH 29 database, we have extracted and reported only high confidence interactions between phytochemicals and target human proteins that have a combined STITCH score ≥700. Note that our choice of STITCH database to predict interactions between IMPPAT phytochemicals and target human proteins was based on similar choice made by the traditional Chinese medicine database TCM-Mesh 16 . Small molecule collections of commercial compounds, diverse compounds, natural products and phytochemicals from Chinese medicinal plants. We 78 have compiled small molecule collections from three different sources, namely, commercial compounds (CC), diversity-oriented synthesis compounds (DC') and natural products (NP). CC contains 6152 representative small molecules from commercial sources. DC' contains 5963 small molecules synthesized by academic community using methods like diversity-oriented synthesis. NP contains 2477 small molecules from natural products. We remark that 11, 3 and 147 small molecules in CC, DC' and NP collections, respectively, are also contained in the set of 9596 IMPPAT phytochemicals. Note that the computation of physicochemical properties failed for 3 small molecules in CC and 3 small molecules in DC' , and we omitted these small molecules from subsequent analysis.
In addition, we have also extracted the set of 10140 phytochemicals produced by 6235 Chinese medicinal plants or herbs from TCM-Mesh 16  Similarity of phytochemicals. Tanimoto coefficient (Tc) 92 is a widely used measure to compute structural similarity between chemicals 93 . To evaluate the structural similarity of chemicals within our database to known drugs using Tc, we employed two molecular fingerprints: (a) Extended Circular Fingerprints (ECFP4) 94 applying Morgan algorithm 95 with radius value of 2 as implemented in RDKit 21 , and (b) MACCS keys based fingerprint.
We employed the open source package, RDKit 21 , to compute molecular fingerprints and Tc between pairs of chemical structures. To identify structural similarity between chemicals, a stringent cut-off of Tc ≥0.5 was used while employing ECFP4 and a cut-off of Tc ≥0.85 was used while employing MACCS keys. Our selection of Tc cut-offs for ECFP4 and MACCS keys based computations was motivated by the recent work of Jasial et al. 96 .
We obtained a list of 2069 FDA approved drugs from DrugBank 19 database and computed their structural similarity with druggable IMPPAT phytochemicals using both ECFP4 and MACCS keys based molecular fingerprints. Note that ECFP4 molecular fingerprints were used to create the chemical similarity network of the druggable phytochemicals with QEDw score ≥0.9. Besides quantifying the structural similarity based on the Tc of phytochemicals, we have employed principal component analysis (PCA) to explore possible relationships between druggable phytochemicals with QEDw score ≥0.9 based on their physicochemical properties.

Database management and network visualization.
To construct this database, the compiled and curated data was integrated using MySQL (https://www.mysql.com/), a relational database management system which serves as a back-end for our resource. The web interface for the database was built using Drupal (https:// www.drupal.org/), a PHP-based content management system hosted on Apache server with the MySQL database in the back-end. Users can browse or query our database using the scientific names of Indian medicinal plants, standard identifiers for phytochemicals, or associated therapeutic uses (Fig. 2). Further we have integrated the Cytoscape.js application 97 (http://js.cytoscape.org/) into our web interface which enables visualization of plant-phytochemical associations, plant-therapeutic associations, and plant-formulation associations in the form of a network. The Cytoscape network visualization displays different types of nodes such as plant, phytochemical, therapeutic use and traditional medicinal formulations in different shapes and colours. Finally, the association network can be downloaded as a tab-separated list using the available export option in our database (Fig. 2). Data availability. The datasets generated and analysed in this study are openly accessible at: https://cb.imsc. res.in/imppat.

Results
Web-interface of the database. The IMPPAT database captures information on three types of associations for Indian medicinal plants: phytochemical composition, therapeutic uses, and traditional medicinal formulations (Fig. 1). The web-interface of the database enables users to query for each of these associations using (a) scientific names of plants, (b) standard chemical identifiers of phytochemicals, (c) therapeutic uses, or (d) formulation identifiers (Fig. 2). The web-interface displays the result of user queries for these associations in two ways: (a) A table of associations with references to literature sources, and (b) A network visualization of the associations which is powered by Cytoscape.js 97 (Fig. 2). In addition, users can also download the result of their queries for different associations of medicinal plants as a tab-separated list using the available export option in the web-interface. In the results page of queries for plant-phytochemical associations, users can click each phytochemical name or identifier to navigate to a separate page containing detailed information such as chemical structure, alternate chemical names or identifiers, computed physicochemical properties, computed druggability scores, predicted ADMET properties, predicted human target proteins and the option to download the 2D or 3D chemical structure file in several formats ( Fig. 2; Methods). Queries for plant-therapeutic associations leads to a page where users can also obtain the disease ontology identifiers corresponding to therapeutic uses ( Fig. 2; Methods). In the results page of queries for plant-formulation associations, users can click the medicinal formulation identifiers to navigate to the corresponding page in the TKDL database. Moreover, in the advanced search page of IMPPAT database (Fig. 2), users can filter phytochemicals based on physicochemical properties (e.g., molecular weight, number of hydrogen bond acceptors), or filter phytochemicals satisfying various druggability scores (e.g. RO5, Traffic Lights), or search for phytochemicals similar to query chemical compound. To run the similarity filter, users will have to provide the query compound in the form of Canonical SMILES and choose a molecular fingerprint (ECFP4 or MACCS keys) to compute Tc between the query compound and IMPPAT phytochemicals. The chemical similarity filter will list top 10 IMPPAT phytochemicals which are similar to the input query compound based on Tc. Table S2 Fig. 4c gives the mean and median of the distribution for six physicochemical properties, namely, molecular weight, logP, TPSA, number of hydrogen bond donors, number of hydrogen bond acceptors and number of rotatable bonds for the 9596 IMPPAT phytochemicals. Moreover, we have predicted several ADMET properties for the 9596 IMPPAT phytochemicals (Methods). For example, HIA model predicts 89% of IMPPAT phytochemicals have good intestinal absorption and carcinogenicity model predicts 94% of IMPPAT phytochemicals are non-carcinogenic.

Network of plant-phytochemical associations, plant-therapeutic use associations, and plant-traditional medicinal formulation associations. IMPPAT database contains information on the phytochemical composition and therapeutic uses of 1742 Indian medicinal plants (Supplementary
Small molecules which are specific protein binders in screening assays are more favourable candidates for drug discovery pipeline than promiscuous binders which might interact with many proteins in a screening assay. Clemons et al. 78 have correlated two simple size-independent metrics, namely, stereochemical complexity and shape complexity (Fsp 3 ) 79 with the binding specificity of representative compound collections, CC, DC' and NP (Methods). Clemons et al. 78 found that DC' and NP collections have more stereochemical complexity and shape complexity in comparison to CC collection, and interestingly, small molecules in DC' and NP collections were shown to be more specific binders with less fraction of promiscuous binders in comparison to small molecules in CC collection. We have compared the distribution of stereochemical complexity and Fsp 3 across 9596 IMPPAT  78 and 10140 TCM-Mesh 16 phytochemicals from Chinese medicinal plants (Fig. 4a-b; Methods). Interestingly, we find the mean and median of stereochemical complexity of IMPPAT phytochemicals is higher than CC and DC' collections while being closer to NP collection (Fig. 4a). Furthermore, the mean and median of stereochemical complexity of IMPPAT phytochemicals was found to be much closer to TCM-Mesh phytochemicals in comparison to DC' , CC or even NP collection (Fig. 4a). We also obtain similar trends for the mean and median of shape complexity (Fsp 3 ) of IMPPAT phytochemicals (Fig. 4b). These observations underscore that the IMPPAT phytochemicals are closer to small molecule libraries of natural products or phytochemicals from Chinese medicinal plants in terms of stereochemical complexity and Fsp 3 , and thus, are more likely enriched with specific binders than promiscuous binders.
In a later study, Clemons et al. 98 have also shown that the small molecules in CC, DC' and NP occupy different regions in the physicochemical space. By considering six physicochemical properties studied by Clemons et al. 98 , namely, molecular weight, logP, TPSA, number of hydrogen bond donors, number of hydrogen bond acceptors and number of rotatable bonds, we have compared the physicochemical properties of CC, DC' , NP and TCM-Mesh phytochemicals with IMPPAT phytochemicals (Fig. 4c). In terms of the six physicochemical properties, the IMPPAT phytochemicals are found to be more similar to TCM-Mesh phytochemicals in comparison to NP, DC' or CC (Fig. 4c). The above results underscore the importance of our curated collection of 9596 IMPPAT phytochemicals from Indian medicinal plants which will be a valuable addition to natural product-based screening collections.

Druggability analysis of phytochemicals of Indian medicinal plants.
We evaluated the druggability of 9596 IMPPAT phytochemicals based on multiple rules or scoring schemes, namely, RO5 23 , Traffic Lights 24 , GSK's 4/400 25 , Pfizer's 3/75 26 , Veber rule 27 and Egan rule 28 which were computed using FAF-Drugs4 webserver 20 (Methods). The horizontal bar plot in Fig. 5a gives the number of IMPPAT phytochemicals that satisfy different druggability scores. From this figure, it is seen that the majority of IMPPAT phytochemicals satisfy Veber rule or Egan rule in comparison to Pfizer's 3/75 rule or net Traffic Lights value of zero. Furthermore, we find that the same set of 8712 IMPPAT phytochemicals satisfy both the Veber rule and Egan rule for drug-likeliness. The vertical bar plot of Fig. 5a shows the overlap between sets of phytochemicals that satisfy different druggability scores. We found that 960 out of 9596 IMPPAT phytochemicals satisfy all evaluated druggability scores (Fig. 5a). Subsequently, we designated this filtered list of 960 IMPPAT phytochemicals as druggable. Among the 1742 Indian medicinal plants in our database, Brassica oleracea, Catharanthus roseus, Zea mays, Oryza sativa, Vigna radiate, Pisum sativum, Anethum sowa, Allium cepa, Cassia obtusifolia and Camellia sinensis produce the highest number of druggable phytochemicals, and Supplementary Table S3 gives the number of druggable phytochemicals for each plant in IMPPAT database. In Fig. 5b, we show the distribution of the 960 druggable IMPPAT phytochemicals across different chemical super-classes obtained using ClassyFire 50 . Among the chemical super-classes, phenylpropanoids and polyketides, organoheterocyclic compounds, and lipids and lipid-like molecules are the top three with 218, 182 and 137 phytochemicals, respectively ( Fig. 5b; Methods). Among the chemical classes, organooxygen compounds, prenol lipids, and flavonoids are the top three with 111, 97 and 96 phytochemicals, respectively. Moreover, organooxygen class includes many carbohydrates, carbonyl compounds and alcohols while the prenol lipids class mainly comprises different types of terpenes and terpenoids. Figure 5c shows the distribution of QEDw 91 scores for the 960 druggable IMPPAT phytochemicals with mean score of 0.57 and standard deviation of 0.17 (Methods). From this figure, it is seen that 14 druggable phytochemicals have a QEDw score ≥0.9 and 98 druggable phytochemicals have a QEDw score ≥0.8.
By comparing the 2069 FDA approved drugs from the DrugBank 19 with the 960 druggable IMPPAT phytochemicals, we found that only 32 FDA approved drugs are among the 960 phytochemicals while the remaining 928 phytochemicals are potential new hits. By investigating the structural similarity between 2069 FDA approved drugs and 960 druggable IMPPAT phytochemicals, we found that 249 and 302 druggable phytochemicals are similar to FDA approved drugs based on ECFP4 or MACCS keys molecular fingerprints, respectively ( Fig. 5d; Methods). Combined, ECFP4 and MACCS keys based fingerprints identified 369 out of 960 druggable IMPPAT phytochemicals that are similar to FDA approved drugs (Methods). Thus, almost 40% of the druggable IMPPAT phytochemicals are similar to at least one FDA approved drug which testifies to our systemic approach to identify potential druggable phytochemicals of Indian medicinal plants. Importantly, the remaining 591 druggable IMPPAT phytochemicals which have no similarity with any of the FDA approved drugs are novel candidates for designing new drugs based on natural products from Indian medicinal plants.
For subsequent analysis, we selected 14 druggable phytochemicals with QEDw score 91 ≥0.9 which were designated as the most-druggable phytochemicals. Of these 14 phytochemicals, 12 were found to be similar to at least one of the FDA approved drugs based on either ECFP4 or MACCS keys based molecular fingerprint. The remaining 2 most-druggable phytochemicals, Onosmone (CID:102212116) and Truxillic acid (CID:78213), were found to have no similarity with any of the FDA approved drugs. Supplementary Figure S1a displays the similarity matrix based on Tc obtained using ECFP4 molecular fingerprint for the 14 most-druggable phytochemicals (Methods). From the similarity matrix, it is seen that 75 of the 91 Tc values between the 14 most-druggable phytochemicals are <0.5 implying high structural diversity. Moreover, the similarity matrix can be transformed into a similarity network for the 14 most-druggable phytochemicals by using a stringent threshold value of Tc ≥0.5 to determine edges in the graph (Supplementary Figure S1b; Methods). The similarity network for the 14 most-druggable phytochemicals has 16 edges and can be partitioned into a large connected component (cluster) of 7 phytochemicals, a smaller connected component of 2 phytochemicals and 5 remaining isolated phytochemicals. We highlight that the 2 phytochemicals, Onosmone and Truxillic acid, that have no similarity with any of the FDA approved drugs are among the isolated nodes in the similarity network (Supplementary Figure S1b). Based on plant-phytochemical associations in our database, Onosmone and Truxillic acid are phytochemicals of Indian medicinal plants, Onosma echioides and Erythroxylum coca, respectively, and a survey of the literature shows that (d) Venn diagrams summarizing structural similarity analysis of 960 druggable phytochemicals in IMPPAT database and FDA approved drugs. Based on ECFP4 and MACCS keys molecular fingerprints, 249 and 302 druggable phytochemicals, respectively, were found to be similar to FDA approved drugs. these phytochemicals are under active investigation for their therapeutic uses [99][100][101][102][103] . We also highlight that none of the 14 most-druggable phytochemicals are captured by Phytochemica 11 database while 6 of the 14 phytochemicals are captured by Nutrichem 9,10 database.
We also investigated the physicochemical properties of the 14 most-druggable phytochemicals. A principal component analysis (PCA) of the 14 most-druggable phytochemicals based on their physiochemical properties revealed that the first and second principal components together explained 69% of the total variance in the dataset (Supplementary Figure S1c). We find that some of the 7 most-druggable phytochemicals which are clustered together in the structural similarity space (Supplementary Figure S1b) are not clustered together in the physicochemical space (Supplementary Figure S1c). These observations based on limited analysis of 14 most-druggable phytochemicals suggest that a combined exploration of structural similarity space, physicochemical space and biological activity space of IMPPAT phytochemicals will facilitate identification and design of novel drugs. Thus, in future, it will be also worthwhile to compile biological activity profiles for phytochemicals of Indian medicinal plants.
Comparison with phytochemical space of Chinese medicinal plants. We  . By comparing the 9596 IMPPAT phytochemicals with 10140 TCM-Mesh phytochemicals, we find that less than 25%, specifically 2305 phytochemicals, are common between the two databases (Fig. 6a). Among the 9596 IMPPAT phytochemicals, a subset of 960 phytochemicals were found to be druggable based on multiple druggability scores, namely, RO5 23 , Traffic Lights 24 , GSK's 4/400 25 , Pfizer's 3/75 26 , Veber rule 27 and Egan rule 28 (Fig. 5a). Among the 10140 TCM-Mesh phytochemicals, we found a subset of 972 phytochemicals to be druggable based on multiple druggability scores listed above (Fig. 6b). Thus, the relative size of the filtered subset of druggable phytochemicals is very similar for IMPPAT database (10%) on Indian medicinal plants and TCM-Mesh database (9.6%) on Chinese medicinal plants. Figure 6c shows the distribution of QEDw 91 scores for the 972 druggable TCM-Mesh phytochemicals with mean score of 0.58 and standard deviation of 0.16, and thus, this distribution is similar to that for 960 druggable IMPPAT phytochemicals shown in Fig. 5c. By comparing the set of FDA approved drugs with the subset of druggable phytochemicals in IMPPAT and TCM-Mesh, we find that 32 approved drugs are contained in 960 IMPPAT phytochemicals while 19 approved drugs are contained in 972 TCM-Mesh phytochemicals. Thus, we find that majority of druggable phytochemicals in both IMPPAT (928 phytochemicals) and TCM-Mesh (953 phytochemicals) are potential hits for future drug discovery. Lastly, we find only a small overlap of 242 phytochemicals between the set of 960 druggable IMPPAT phytochemicals and 972 druggable TCM-Mesh phytochemicals (Fig. 6d), and thus, phytochemicals from both Indian herbs and Chinese herbs offer extensive opportunity for novel drug discovery.

Discussion and future directions
Cheminformatics can accelerate drug discovery from diverse natural sources 5 . We here incorporate cheminformatic principles to build an extensive resource on phytochemistry and ethnopharmacology of Indian medicinal plants. Here we present, IMPPAT, a curated database of 1742 Indian Medicinal Plants, 9596 Phytochemicals, And 1124 T herapeutic uses which is the largest, freely accessible, digital resource on natural products from Indian herbs to date. IMPPAT provides chemical classification, 2D and 3D chemical structure, physicochemical properties, predicted ADMET properties, drug-likeliness scores and predicted human target proteins for phytochemicals in the database, and the available information in the database can be used for virtual screening. IMPPAT also captures limited information on the associations between Indian medicinal plants and their use in traditional Indian medicinal formulations. Thus, IMPPAT provides a unifying platform for the application of computational approaches to elucidate mechanistic links between phytochemicals of Indian medicinal plants and their therapeutic action.
Following Clemons et al. 78 , we have compared the distributions of stereochemical complexity and shape complexity (Fsp 3 ) across 9596 IMPPAT phytochemicals with small molecule collections, CC, DC' and NP and 10140 TCM-Mesh 16 phytochemicals from Chinese medicinal plants (Fig. 4a-b). Interestingly, we show that the mean and median of stereochemical complexity or shape complexity of IMPPAT phytochemicals is closer to NP or TCM-Mesh phytochemicals than CC or DC' collections. Following Clemons et al. 98 , we have also compared six physicochemical properties of CC, DC' , NP and TCM-Mesh phytochemicals with IMPPAT phytochemicals (Fig. 4c) to show that IMPPAT phytochemicals are closer to TCM-Mesh phytochemicals in physicochemical space (Fig. 4c). These results suggest that the IMPPAT library of phytochemicals is more likely to be enriched for specific protein binders rather than promiscuous binders 78 , and thus, our phytochemical library is expected to be a valuable addition to natural product-based screening collections.
Using cheminformatic approaches, we found that 960 of the 9596 IMPPAT phytochemicals of Indian medicinal plants are potentially druggable based on multiple scoring schemes. Of the 960 IMPPAT phytochemicals which satisfy all druggability scores evaluated here, a subset of 14 phytochemicals were found to have a QEDw 91 score ≥0.9 (Supplementary Figure S1). Interestingly, the occurrence of these 14 most-druggable phytochemicals across 1742 Indian medicinal plants in our database is very rare with none of the 14 phytochemicals being found in more than 3 Indian medicinal plants. Specifically, the 14 most-druggable phytochemicals are constituents of only 17 Indian medicinal plants in our database. Also, 4 of the 14 most-druggable phytochemicals are constituents of 3 phylogenetically close Indian medicinal plants, Iris germanica, Iris nepalensis and Iris kemaonensis, which are from the same genus. However, we find that only 2 out of 17 Indian medicinal plants that produce the 14 most-druggable phytochemicals are in the priority list of Ministry of AYUSH, Government of India. This analysis suggests a possible revision in the AYUSH priority list to include the remaining 15 Indian medicinal plants that produced the majority of the most-druggable phytochemicals in our database. Thus, our resource will also aid in future expansion of the chemotaxonomy 104 of Indian medicinal plants.
Lastly, we have also compared the IMPPAT phytochemicals from Indian herbs with the TCM-Mesh 16 phytochemicals from Chinese herbs to show that roughly 75% of the phytochemicals are unique to each database (Fig. 6). Moreover, we found that the filtered subsets of druggable phytochemicals in IMPPAT and TCM-Mesh are similar in size with roughly 75% of druggable phytochemicals unique to each database (Fig. 6). Furthermore, among the 960 and 972 druggable phytochemicals in IMPPAT and TCM-Mesh, respectively, a small fraction of 32 and 19 approved FDA drugs are contained in IMPPAT and TCM-Mesh, respectively. In sum, our results underline the vast potential of both Indian and Chinese herbs for future drug discovery.
In the future, we hope to update IMPPAT database with the following additional information. Firstly, it will be important to update our database with more detailed information on the parts of the Indian medicinal plants such as leaves, stem or root, that produce the different phytochemicals along with relative composition of phytochemicals in different parts of the plants. Such detailed information on the relative phytochemical composition of parts of Indian medicinal plants will be crucial for evaluating and developing traditional Indian medicine formulations 74 . However, significant manual curation and literature mining will be needed to expand our database to include the relative phytochemical composition of the different parts of 1742 Indian medicinal plants which is beyond the scope of the present work. Secondly, it will be important to enrich our database by incorporating more traditional Indian medicinal formulations. For example, TKDL (http://www.tkdl.res.in) has made only 1200 of their documented 250000 traditional Indian medicinal formulations openly accessible, and future efforts to associate this wealth of information to our database will shed mechanistic information on the therapeutic action of traditional formulations. Thirdly, it will be important to compile known biological activity information for phytochemicals of Indian medicinal plants. In conclusion, IMPPAT database will serve as a valuable resource in herbal drug discovery.